NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré syndrome

This study aimed at identifying human neural proteins that can be attacked by cross-reacting SARS-COV-2 antibodies causing Guillain-Barré syndrome. These markers can be used for the diagnosis of Guillain-Barré syndrome (GBS). To achieve this goal, proteins implicated in the development of GBS were r...

Descripción completa

Detalles Bibliográficos
Autor principal: Morsy, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543761/
https://www.ncbi.nlm.nih.gov/pubmed/33069093
http://dx.doi.org/10.1016/j.mehy.2020.110342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543761/
https://www.ncbi.nlm.nih.gov/pubmed/33069093
http://dx.doi.org/10.1016/j.mehy.2020.110342

Ejemplares similares